Olema Pharmaceuticals, Inc. (OLMA)
7.09
+0.51
(+7.75%)
USD |
NASDAQ |
Oct 19, 15:29
Olema Pharmaceuticals Cash from Operations (Annual) : -146.72M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -146.72M |
| December 31, 2024 | -104.35M |
| December 31, 2023 | -83.73M |
| December 31, 2022 | -82.06M |
| Date | Value |
|---|---|
| December 31, 2021 | -50.69M |
| December 31, 2020 | -19.87M |
| December 31, 2019 | -3.081M |
| December 31, 2018 | -2.176M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| SELLAS Life Sciences Group, Inc. | -28.39M |
| Puma Biotechnology, Inc. | 41.80M |
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Anika Therapeutics, Inc. | 11.19M |